Original Source
Daphne Koller on AI-powered Drug Discovery in Washington Post Interview
AI Driving Innovation in Drug Discovery
The Washington Post recently highlighted the present and future of AI-powered drug discovery through an interview with Daphne Koller. Koller emphasized that AI can bring innovation across the pharmaceutical industry, from drug candidate discovery to clinical trials. The ability of AI to analyze vast amounts of data and predict complex molecular structures is expected to contribute to solving problems that were difficult to address with traditional methods.
Daphne Koller's Insights as an AI Expert
Daphne Koller, a renowned expert in the AI field, predicted an increasing role for AI in the drug development process. She noted that AI will be a powerful tool helping researchers discover new treatments faster and more efficiently. Positive prospects were presented, suggesting that AI technology could significantly reduce the time and cost involved in drug development, enabling quicker delivery of necessary medications to patients.
*Source: The Washington Post (2026-04-30)*
Related Articles
📧 Daily Newsletter
Get the daily global news briefing in your inbox every morning.
It's still free.